Janice Suchyta is a Partner in the Firm’s Dallas office and a member of the Health Care & Life Sciences practice group. She represents clients in the health care industry, focusing her practice on the strategic, regulatory and operational needs of health systems, hospitals, academic medical centers, Federally Qualified Health Centers (FQHCs), telehealth providers, and digital start-ups. Her experience as in-house counsel for a large health center provides clients with a unique perspective to navigate complex health care matters.
Ms. Suchyta provides strategic and regulatory guidance on the 340B Drug Discount Program, including contract pharmacy arrangements, as well as limited distribution network and other specialty pharmacy models. She has represented specialty pharmacies, health care systems, hospitals, federal grantees, and other 340B covered entities. She routinely represents FQHCs and rural health centers on compliance and regulatory matters related to the Health Center Program. She advises health centers regarding HRSA Operational Site Visits and other government agency audits, billing and contracting advice, guidance on Federal Tort Claims Act coverage and the 340B Drug Discount Program.
Ms. Suchyta also advises digital and medical technology companies and providers on privacy and security matters. The increased use of Software as a Medical Device (MaSD) and artificial intelligence in medical technology presents unique cyber security issues as the FDA and FTC continue to implement regulatory requirements. Ms. Suchyta provides strategic advice to her medical technology clients on cybersecurity, privacy and data protection issues. She has extensive experience advising health care providers and organizations on Medicare and Medicaid reimbursement matters, including regulatory compliance, billing disputes and audit responses. She also counsels hospitals and physician groups on health plan contracting, including negotiating provider agreements, value-based reimbursement models and managed care arrangements. Ms. Suchyta has presented to national ACO organizations regarding value-based care models, including Direct To Employer arrangements.
Ms. Suchyta routinely represents telehealth providers on licensure, credentialing, privileging, online prescribing and corporate practice of medicine matters. She drafts and reviews contracts for digital health products and services and assists health care clients with security and risk analysis obligations under federal and state laws.
Janice Suchyta advises healthcare providers and medical technology companies on the legal, regulatory, and governance challenges posed by artificial intelligence in healthcare. Her practice focuses on HIPAA and data-privacy compliance, AI-enabled healthcare contracting, and risk-based governance frameworks for the development and deployment of clinical and operational AI tools. She regularly represents hospitals, physician groups, and FQHCs, as well as AI and digital health vendors, in structuring compliant data-use strategies, negotiating complex technology agreements, and addressing regulatory, reimbursement, and enforcement risk associated with AI-driven healthcare solutions.
Represented a Fortune 100 energy company in the legal compliance and implementation of an on-site employee health clinic.
Assisted a multi-provider medical clinic in forming a Patient Safety Organization.
Supported a clinically integrated network in the formation and implementation of an Accountable Care Organization.
Represented a medical device company in drafting contracts for digital health products.
Guided a digital health company in developing and implementing a multi-state telehealth platform.
Represented a national health plan in a provider-payer joint venture to establish a Medicare Advantage high-performance network.
Advised a biopharmaceutical company on the development of a telehealth platform for a remote clinical trial program.
Representative AI & Healthcare Technology Matters
Advised health systems, hospitals, and physician groups on the deployment of clinical decision support and generative-AI tools, including HIPAA risk assessments, OCR-defensible governance frameworks, and operational controls for use of PHI in model training and inference.
Represented AI and digital health vendors in negotiating complex healthcare technology agreements, including SaaS, data-license, and enterprise AI contracts with hospitals, FQHCs, and health plans, with a focus on HIPAA compliance, data ownership, model-training rights, and liability allocation.
Structured HIPAA-compliant data-use and development strategies for AI companies working with covered entities, including de-identification methodologies, limited data set frameworks, synthetic data strategies, and compliant Business Associate Agreements.
Counseled healthcare organizations on AI governance and compliance programs, including AI acceptable-use policies, vendor due-diligence checklists, incident-response protocols, and board-level oversight structures aligned with federal and state privacy laws.
Advised technology companies on regulatory risk associated with AI-enabled clinical, revenue-cycle, and operational tools, including FDA enforcement discretion, false claims exposure, algorithmic bias risk, and downstream provider liability.
Guided healthcare entities through AI-related data-privacy issues, including HIPAA, state consumer health data laws, and emerging AI-specific statutes, with particular focus on secondary use of clinical data and vendor access controls.
Negotiated data-sharing and interoperability arrangements involving AI vendors, EHR platforms, and healthcare providers, addressing IP ownership, audit rights, security obligations, and restrictions on competitive use of healthcare data.
Advised clients on AI risk in reimbursement and compliance contexts, including use of AI in coding, documentation improvement, utilization management, and medical necessity determinations.
Supported healthcare and technology clients in internal investigations and risk mitigation involving AI-related data use, model errors, or privacy incidents, including remediation planning and regulatory response strategies.
Education
University of Detroit, Mercy School of Law, J.D.
University of Michigan, B.A. in English Language and Literature
Member, American Health Lawyers Association
Vice Chair of Publications, Government Affinity Group (2020–2021)
Leadership Development Program (2019–2020)
Member, Texas State Bar Association, Health Law Section
Board Chair 2020-2021, Fort Bend Chamber of Commerce
